Skip to main content

Table 1 Structure, log P value, stability, and pharmacokinetics of DAC and 5′-O-trialkylsilylated DACs

From: Novel prodrugs of decitabine with greater metabolic stability and less toxicity

 

DAC

OR-2003

OR-2009

OR-2100

OR-2102

 

R 1

H

H

H

H

H

R 2

H

H

H

H

H

R3 = R4

H

H

H

H

H

R 5

Methyl

Methyl

Ethyl

Ethyl

R 6

Methyl

Methyl

Ethyl

Ethyl

R 7

n-Propyl

c-Hexyl

Ethyl

n-Propyl

Log P value

− 0.32

1.64

2.52

2.14

2.54

Stability

t1/2 in PBS

20 h*

20** + 1 h

20** + 14 h

20** + 16 h

20** + 19 h

Enzymatic

Complete degradation after 0.5 h

Retain 52% after 1 h

Retain 75% after 2 h

Retain 84% after 2 h

Retain 46% after 2 h

AUC 0 → lim (μM·hr)

OR compound

0.305

0.314

0.168

0.081

DAC

0.378

0.338

0.238

0.266

0.285

Total

0.378

0.643

0.552

0.434

0.366

  1. DAC decitabine, PBS phosphate-buffered saline
  2. *Reference: Yoo C.B. et al. Cancer Research 2007; 67:6400–6408
  3. **20 h: t1/2 in PBS of DAC